$RPRX Royalty Pharma plc Insider Trading Week 25/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Royalty Pharma plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Royalty Pharma plc in week 25/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2020 | RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Option Exercise | C | 0.00 | 2,327 | 0 | 181 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Option Exercise | A | 0.00 | 48,000 | 0 | 48,000 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Option Exercise | A | 0.00 | 305,000 | 0 | 305,000 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Option Exercise | A | 0.00 | 2,508 | 0 | 2,508 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Option Exercise | A | 0.00 | 406,491 | 0 | 406,491 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Option Exercise | A | 0.00 | 10,755 | 0 | 10,755 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Buy | C | 0.00 | 23,270 | 0 | 23,270 | 0 to 23.3 K |
| Jun 23 2020 | RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Buy | P | 28.00 | 1,450 | 40,600 | 1,450 | 0 to 1.5 K |
| Jun 23 2020 | RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Buy | P | 28.00 | 1,500 | 42,000 | 1,500 | 0 to 1.5 K |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 119,982 | 0 | 119,982 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 494,485 | 0 | 494,485 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 253,889 | 0 | 253,889 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 435,267 | 0 | 435,267 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 238,001 | 0 | 238,001 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Buy | P | 28.00 | 15,000 | 420,000 | 15,000 | 0 to 15 K |
| Jun 23 2020 | RPRX | Royalty Pharma plc | Hite Christopher | EVP & Vice Chairman | Option Exercise | A | 0.00 | 116,100 | 0 | 116,100 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | Hite Christopher | EVP & Vice Chairman | Option Exercise | A | 0.00 | 62,500 | 0 | 62,500 | |
| Jun 23 2020 | RPRX | Royalty Pharma plc | Hite Christopher | EVP & Vice Chairman | Buy | P | 28.00 | 70,000 | 1,960,000 | 70,000 | 0 to 70 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Option Exercise | C | 0.00 | 2,503 | 0 | 195 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Option Exercise | C | 0.00 | 2,503 | 0 | 195 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Option Exercise | A | 0.00 | 2,698 | 0 | 2,698 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Option Exercise | A | 0.00 | 2,698 | 0 | 2,698 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Option Exercise | A | 0.00 | 631,468 | 0 | 631,468 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Option Exercise | A | 0.00 | 631,468 | 0 | 631,468 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Option Exercise | A | 0.00 | 29,117 | 0 | 29,117 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Option Exercise | A | 0.00 | 29,117 | 0 | 29,117 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Buy | C | 0.00 | 25,030 | 0 | 25,030 | 0 to 25 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Reddoch James F. | EVP, Research & Inv ... | Buy | C | 0.00 | 25,030 | 0 | 25,030 | 0 to 25 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | C | 0.00 | 11,850 | 0 | 924 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | C | 0.00 | 11,850 | 0 | 924 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | C | 0.00 | 12,331 | 0 | 962 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | C | 0.00 | 12,331 | 0 | 962 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 1,677,574 | 0 | 1,677,574 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 1,677,574 | 0 | 1,677,574 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 12,774 | 0 | 12,774 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 12,774 | 0 | 12,774 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 13,293 | 0 | 13,293 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 13,293 | 0 | 13,293 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 4,868,033 | 0 | 4,868,033 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 4,868,033 | 0 | 4,868,033 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 138,479 | 0 | 138,479 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 138,479 | 0 | 138,479 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 112,156 | 0 | 112,156 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 112,156 | 0 | 112,156 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 942,738 | 0 | 942,738 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Option Exercise | A | 0.00 | 942,738 | 0 | 942,738 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Buy | C | 0.00 | 118,500 | 0 | 118,500 | 0 to 118.5 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Buy | C | 0.00 | 118,500 | 0 | 118,500 | 0 to 118.5 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Buy | C | 0.00 | 123,310 | 0 | 123,310 | 0 to 123.3 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Buy | C | 0.00 | 123,310 | 0 | 123,310 | 0 to 123.3 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Buy | P | 28.00 | 10,000 | 280,000 | 10,000 | 0 to 10 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Buy | P | 28.00 | 10,000 | 280,000 | 10,000 | 0 to 10 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Buy | P | 28.00 | 10,000 | 280,000 | 10,000 | 0 to 10 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of th ... | Buy | P | 28.00 | 10,000 | 280,000 | 10,000 | 0 to 10 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | FORD WILLIAM E | Director | Option Exercise | A | 0.00 | 76,127 | 0 | 76,127 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | FORD WILLIAM E | Director | Option Exercise | A | 0.00 | 76,127 | 0 | 76,127 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | FORD WILLIAM E | Director | Option Exercise | A | 0.00 | 171,350 | 0 | 171,350 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | FORD WILLIAM E | Director | Option Exercise | A | 0.00 | 171,350 | 0 | 171,350 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | FORD WILLIAM E | Director | Option Exercise | A | 0.00 | 2,667,385 | 0 | 2,667,385 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | FORD WILLIAM E | Director | Option Exercise | A | 0.00 | 2,667,385 | 0 | 2,667,385 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | FORD WILLIAM E | Director | Buy | P | 28.00 | 1,500,000 | 42,000,000 | 1,500,000 | 0 to 1.5 M |
| Jun 22 2020 | RPRX | Royalty Pharma plc | FORD WILLIAM E | Director | Buy | P | 28.00 | 1,500,000 | 42,000,000 | 1,500,000 | 0 to 1.5 M |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | C | 0.00 | 26,276 | 0 | 2,050 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | C | 0.00 | 26,276 | 0 | 2,050 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | A | 0.00 | 353,000 | 0 | 353,000 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | A | 0.00 | 353,000 | 0 | 353,000 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | A | 0.00 | 28,326 | 0 | 28,326 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | A | 0.00 | 28,326 | 0 | 28,326 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | A | 0.00 | 596,707 | 0 | 596,707 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | A | 0.00 | 596,707 | 0 | 596,707 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | A | 0.00 | 83,638 | 0 | 83,638 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | A | 0.00 | 83,638 | 0 | 83,638 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | A | 0.00 | 7,730 | 0 | 7,730 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | A | 0.00 | 7,730 | 0 | 7,730 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Buy | C | 0.00 | 262,760 | 0 | 273,960 | 11.2 K to 274 K (+2,346.07 %) |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Buy | C | 0.00 | 262,760 | 0 | 273,960 | 11.2 K to 274 K (+2,346.07 %) |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Buy | P | 28.00 | 11,200 | 313,600 | 11,200 | 0 to 11.2 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Buy | P | 28.00 | 11,200 | 313,600 | 11,200 | 0 to 11.2 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Buy | P | 28.00 | 3,000 | 84,000 | 3,000 | 0 to 3 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Buy | P | 28.00 | 3,000 | 84,000 | 3,000 | 0 to 3 K |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | C | 0.00 | 2,292,617 | 0 | 178,821 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | C | 0.00 | 2,292,617 | 0 | 178,821 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | C | 0.00 | 2,339,999 | 0 | 182,438 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | C | 0.00 | 2,339,999 | 0 | 182,438 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | C | 0.00 | 347,752 | 0 | 2,032 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | C | 0.00 | 347,752 | 0 | 2,032 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | C | 0.00 | 907,714 | 0 | 70,800 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | C | 0.00 | 907,714 | 0 | 70,800 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | A | 0.00 | 349,784 | 0 | 349,784 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | A | 0.00 | 349,784 | 0 | 349,784 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | A | 0.00 | 978,514 | 0 | 978,514 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Option Exercise | A | 0.00 | 978,514 | 0 | 978,514 | ||
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Buy | P | 28.00 | 50,000 | 1,400,000 | 50,000 | 0 to 50 K | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Buy | P | 28.00 | 50,000 | 1,400,000 | 50,000 | 0 to 50 K | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Buy | C | 0.00 | 22,926,170 | 0 | 22,926,170 | 0 to 22.9 M | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Buy | C | 0.00 | 22,926,170 | 0 | 22,926,170 | 0 to 22.9 M | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Buy | C | 0.00 | 23,390,000 | 0 | 23,390,000 | 0 to 23.4 M | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Buy | C | 0.00 | 23,390,000 | 0 | 23,390,000 | 0 to 23.4 M | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Buy | C | 0.00 | 3,477,520 | 0 | 3,477,520 | 0 to 3.5 M | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Buy | C | 0.00 | 3,477,520 | 0 | 3,477,520 | 0 to 3.5 M | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Buy | C | 0.00 | 9,077,140 | 0 | 9,077,140 | 0 to 9.1 M | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | Giuliani Mario Germano | Buy | C | 0.00 | 9,077,140 | 0 | 9,077,140 | 0 to 9.1 M | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Option Exercise | C | 0.00 | 4,637,046 | 0 | 335,513 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Buy | P | 28.00 | 3,000,000 | 84,000,000 | 46,015,330 | 43 M to 46 M (+6.97 %) |
| Jun 22 2020 | RPRX | Royalty Pharma plc | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Buy | C | 0.00 | 43,015,330 | 0 | 43,015,330 | 0 to 43 M |